Professor Lou Garrison: Extending the QALY framework for HTA: Exploring the linkages among benefit-risk assessments, stratified medicines, and comparative effectiveness research
Tuesday 9 April 2013
Invited Speaker - Professor Lou Garrison, Pharmaceutical Outcomes Research & Policy Program, Department of Pharmacy, University of Washington. Currently Visiting Senior Research Fellow 2012-3, Office of Health Economics, London, UK
